Novo Nordisk Pharma Pvt Ltd. has signed a Memorandum of Understanding (MoU) with Arogga Ltd, aiming to enhance access and convenience for diabetes patients in Dhaka through digital service delivery.
The agreement will allow patients to order authentic Novo Nordisk products online via Arogga’s platform. Delivery services will be provided within Dhaka city, maintaining strict cold-chain standards throughout the process to ensure product integrity.
As part of the initiative, patients will receive QR-code-based instructional materials to support correct product usage. The collaboration integrates digital technology with healthcare distribution, setting a new benchmark for patient-centred care and pharmaceutical quality assurance in Bangladesh.
The signing ceremony was attended by Dr Mohammad Riad Mamun Pradhani, managing director of Novo Nordisk, and Dr Mahbubur Rahman, director of clinical, medical and regulatory Affairs.
Representing Arogga Ltd were Rozina Mazumder, co-founder and chief executive officer, and Yawer Mehbub, co-founder and chief strategy officer.
